• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS CREATININE PLUS VER.2; ENZYMATIC METHOD, CREATININE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS CREATININE PLUS VER.2; ENZYMATIC METHOD, CREATININE Back to Search Results
Catalog Number 03263991190
Device Problem Low Test Results (2458)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 12/16/2015
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).
 
Event Description
The customer reported that they had an erroneous creatinine plus ver.2 (creat) and an erroneous ion selective electrode (ise) potassium result for one patient sample tested on a c501 analyzer.The sample was collected from the infusion arm of the patient and this infusion contained dopamine.This medwatch will refer to creat.Please refer to the medwatch with patient identifier (b)(6) for information related to ise potassium.The sample resulted as 146.500 umol/l for creat and 4.470 mmol/l for ise potassium on (b)(6) 2015.The initial results were reported outside of the laboratory.The patient was said to usually have a creat value of 312 umol/l, so the initial creat value was questioned by the doctor.A new sample was collected from the patient 3 hours later from the other arm.The new sample resulted as 328.4 umol/l for creat and 5.450 mmol/l for ise potassium on (b)(6) 2015.The patient was not adversely affected.The c501 analyzer serial number was (b)(4).The customer stated that they performed a study where samples were diluted with a 1% infusion solution of 5 mg/ml dobutamide.Samples diluted in this fashion resulted with lower creat concentration.Diluting samples with a 0.5% infusion solution also resulted in lower creat concentration.No specific data was provided for this study.
 
Manufacturer Narrative
A specific root cause could not be determined based on the provided information.The false low results were most likely caused by inappropriate blood drawing techniques.It was stated in the investigation that blood should never be collected proximal to the infusion site as it may cause partial dilution of the sample.Samples should always be collected from the opposite arm.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CREATININE PLUS VER.2
Type of Device
ENZYMATIC METHOD, CREATININE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key5407084
MDR Text Key37440878
Report Number1823260-2016-00097
Device Sequence Number1
Product Code JFY
Combination Product (y/n)N
Reporter Country CodeNL
PMA/PMN Number
K024098
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 02/16/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number03263991190
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/12/2016
Initial Date FDA Received02/03/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received02/16/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Age89 YR
-
-